# Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)

> **NCT00239486** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 109 (—)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Pramipexole

## Key facts

- **NCT ID:** NCT00239486
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2004-04
- **Final completion:** 2004-04
- **Target enrollment:** 109 (—)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239486, "Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00239486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*